{"url_path":"/sec/tbph/8-k/2026-06-29/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 ****Other Events.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1583107/0001104659-26-078453-index.html","accession_number":"0001104659-26-078453","cik":"0001583107","ticker":"TBPH","issuer_name":"Theravance Biopharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1583107/0001104659-26-078453-index.html","primary_entity_key":"0001583107","primary_entity_name":"Theravance Biopharma, Inc."},"word_count":41,"has_tables":true,"body_markdown":"**Item 8.01****Other Events.**\n\n \n\nOn June 29, 2026, the Company issued a press release\nannouncing entry into the Merger Agreement, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K and\nis incorporated herein by reference."}